[Modification of radiogenic changes in hematopoiesis--status and possibilities].
D045930:Anabolic Agents / Q000627:therapeutic use; D000818:Animals; D001803:Blood Transfusion; D003520:Cyclophosphamide / Q000627:therapeutic use; D004731:Endotoxins / Q000627:therapeutic use; D017707:Erythrocyte Transfusion; D006410:Hematopoiesis / Q000187:drug effects / Q000528:radiation effects*; D006801:Humans; D008094:Lithium / Q000627:therapeutic use; D016651:Lithium Carbonate; D051379:Mice; D010288:Parenteral Nutrition; D011832:Radiation Injuries / Q000628:therapy*; D013949:Thymus Extracts / Q000627:therapeutic use; D014508:Urea / Q000031:analogs & derivatives / Q000627:therapeutic use
D045930:Anabolic Agents; D004731:Endotoxins; D013949:Thymus Extracts; D016651:Lithium Carbonate; C033054:2-cyanoethylurea; D003520:Cyclophosphamide; D014508:Urea; D008094:Lithium
Beeinflussung radiogener Veränderungen der Hämatopoese--Stand und Möglichkeiten.